Hetero Labs Ltd V Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HETERO LABS LTD V
HETERO LABS LTD V has eighty-four approved drugs.
There are two tentative approvals on HETERO LABS LTD V drugs.
Summary for Hetero Labs Ltd V
| US Patents: | 0 |
| Tradenames: | 79 |
| Ingredients: | 78 |
| NDAs: | 84 |
Drugs and US Patents for Hetero Labs Ltd V
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hetero Labs Ltd V | LAMIVUDINE | lamivudine | TABLET;ORAL | 203277-002 | Jan 6, 2014 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hetero Labs Ltd V | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 214344-001 | Sep 12, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hetero Labs Ltd V | CINACALCET HYDROCHLORIDE | cinacalcet hydrochloride | TABLET;ORAL | 209403-001 | Oct 7, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
